Pharma & Healthcare
Global Hepatitis A Vaccine Market Size, Manufacturers, Supply Chain, Sales Channel and Clients, 2025-2031
- Jun 12, 25
- ID: 307240
- Pages: 134
- Figures: 132
- Views: 1
In 2024, the global market size of Hepatitis A Vaccine was estimated to be worth US$ 751 million and is forecast to reach approximately US$ 875 million by 2031 with a CAGR of 2.2% during the forecast period 2025-2031.
Hepatitis A vaccine is a vaccine which is against the hepatitis A virus. The Hepatitis A vaccine is available for long-term prevention of HAV infection, Minimum age for HAV vaccination is 1 year. Two types of HAV vaccines are currently available internationally: 1. Formaldehyde-inactivated vaccines: Inactivated HAV vaccines are used in most countries. Monovalent inactivated HAV vaccines are available in paediatric dose (0.5 ml) for children aged 1 year to 15 years, and in adult dose (1 ml). 2. Live attenuated vaccines (based on H2 or LA-1 HAV strains): These vaccines are manufactured and used mainly in China and sporadically in the private sector in India.
The Hepatitis A vaccine market is primarily driven by the increasing awareness of hepatitis prevention, coupled with growing vaccination programs initiated by governments and health organizations globally. As hepatitis A is a highly contagious liver infection, the rising incidence of outbreaks, especially in developing regions, is pushing demand for vaccines. Moreover, the expanding travel industry, where travelers are required to be vaccinated for hepatitis A when visiting certain high-risk regions, is further bolstering market growth. In addition, advancements in vaccine technology and the increasing availability of combination vaccines are also contributing factors. However, the market faces several challenges. One of the primary challenges is the high cost of vaccines, especially in low-income regions, limiting access for vulnerable populations. Additionally, the lack of infrastructure and healthcare facilities in remote areas poses a significant barrier to widespread vaccine distribution. In certain regions, vaccine hesitancy due to misinformation and fear of side effects also hampers market growth, making public health education and outreach essential to overcoming these obstacles.
Global hepatitis a vaccine key players include GSK, Merck, Sanofi, etc. Global top 5 manufacturers hold a share over 80%. Asia-Pacific is the largest market, with a share over 38%, followed by North America and Europe , both have a share over 54%. In terms of product, inactivated vaccine is the largest segment, with a share about 85%. And in terms of application, the largest application is government institution, followed by private sector, etc.
Report Scope
This report aims to provide a comprehensive presentation of the global market for Hepatitis A Vaccine, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Hepatitis A Vaccine.
The Hepatitis A Vaccine market size, estimations, and forecasts are provided in terms of sales volume (K Unit) and revenue ($ millions), considering 2024 as the base year, with history and forecast data for the period from 2020 to 2031. This report segments the global Hepatitis A Vaccine market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Hepatitis A Vaccine manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and regions.
By Company
GSK
Merck
Sanofi
Sinovac
Zhejiang Pukang
Changchun Institute of Biological
KM Biologics
IMBCAMS
Convac
Segment by Type
Inactivated Vaccine
Live Attenuated Vaccine
Segment by Application
Government Institution
Private Sector
Other
By Region
North America
United States
Canada
Asia-Pacific
China
Japan
South Korea
India
Southeast Asia
Australia
Rest of Asia-Pacific
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Rest of Europe
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type and by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Sales (consumption), revenue of Hepatitis A Vaccine in global and regional level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space of each country in the world.
Chapter 3: Detailed analysis of Hepatitis A Vaccine manufacturers competitive landscape, price, sales, revenue, market share and industry ranking, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides profiles of key manufacturers, introducing the basic situation of the main companies in the market in detail, including product descriptions and specifications, Hepatitis A Vaccine sales, revenue, price, gross margin, sales by region, by Type, by Application, and recent development, etc.
Chapter 5: Provides the analysis of various market segments by Type, covering the sales, revenue, average price, and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 6: Provides the analysis of various market segments by Application, covering the sales, revenue, average price, and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 7: North America by Type, by Application and by country, sales, and revenue for each segment.
Chapter 8: APAC by Type, by Application and by country, sales, and revenue for each segment.
Chapter 9: Europe by Type, by Application and by country, sales, and revenue for each segment.
Chapter 10: Latin America by Type, by Application and by country, sales, and revenue for each segment.
Chapter 11: Middle East and Africa by Type, by Application and by country, sales, and revenue for each segment.
Chapter 12: Analysis of industrial chain, sales channel, key raw materials, distributors, and customers.
Chapter 13: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 14: Research Findings and Conclusion.
Hepatitis A vaccine is a vaccine which is against the hepatitis A virus. The Hepatitis A vaccine is available for long-term prevention of HAV infection, Minimum age for HAV vaccination is 1 year. Two types of HAV vaccines are currently available internationally: 1. Formaldehyde-inactivated vaccines: Inactivated HAV vaccines are used in most countries. Monovalent inactivated HAV vaccines are available in paediatric dose (0.5 ml) for children aged 1 year to 15 years, and in adult dose (1 ml). 2. Live attenuated vaccines (based on H2 or LA-1 HAV strains): These vaccines are manufactured and used mainly in China and sporadically in the private sector in India.
The Hepatitis A vaccine market is primarily driven by the increasing awareness of hepatitis prevention, coupled with growing vaccination programs initiated by governments and health organizations globally. As hepatitis A is a highly contagious liver infection, the rising incidence of outbreaks, especially in developing regions, is pushing demand for vaccines. Moreover, the expanding travel industry, where travelers are required to be vaccinated for hepatitis A when visiting certain high-risk regions, is further bolstering market growth. In addition, advancements in vaccine technology and the increasing availability of combination vaccines are also contributing factors. However, the market faces several challenges. One of the primary challenges is the high cost of vaccines, especially in low-income regions, limiting access for vulnerable populations. Additionally, the lack of infrastructure and healthcare facilities in remote areas poses a significant barrier to widespread vaccine distribution. In certain regions, vaccine hesitancy due to misinformation and fear of side effects also hampers market growth, making public health education and outreach essential to overcoming these obstacles.
Global hepatitis a vaccine key players include GSK, Merck, Sanofi, etc. Global top 5 manufacturers hold a share over 80%. Asia-Pacific is the largest market, with a share over 38%, followed by North America and Europe , both have a share over 54%. In terms of product, inactivated vaccine is the largest segment, with a share about 85%. And in terms of application, the largest application is government institution, followed by private sector, etc.
Report Scope
This report aims to provide a comprehensive presentation of the global market for Hepatitis A Vaccine, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Hepatitis A Vaccine.
The Hepatitis A Vaccine market size, estimations, and forecasts are provided in terms of sales volume (K Unit) and revenue ($ millions), considering 2024 as the base year, with history and forecast data for the period from 2020 to 2031. This report segments the global Hepatitis A Vaccine market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Hepatitis A Vaccine manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and regions.
By Company
GSK
Merck
Sanofi
Sinovac
Zhejiang Pukang
Changchun Institute of Biological
KM Biologics
IMBCAMS
Convac
Segment by Type
Inactivated Vaccine
Live Attenuated Vaccine
Segment by Application
Government Institution
Private Sector
Other
By Region
North America
United States
Canada
Asia-Pacific
China
Japan
South Korea
India
Southeast Asia
Australia
Rest of Asia-Pacific
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Rest of Europe
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type and by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Sales (consumption), revenue of Hepatitis A Vaccine in global and regional level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space of each country in the world.
Chapter 3: Detailed analysis of Hepatitis A Vaccine manufacturers competitive landscape, price, sales, revenue, market share and industry ranking, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides profiles of key manufacturers, introducing the basic situation of the main companies in the market in detail, including product descriptions and specifications, Hepatitis A Vaccine sales, revenue, price, gross margin, sales by region, by Type, by Application, and recent development, etc.
Chapter 5: Provides the analysis of various market segments by Type, covering the sales, revenue, average price, and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 6: Provides the analysis of various market segments by Application, covering the sales, revenue, average price, and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 7: North America by Type, by Application and by country, sales, and revenue for each segment.
Chapter 8: APAC by Type, by Application and by country, sales, and revenue for each segment.
Chapter 9: Europe by Type, by Application and by country, sales, and revenue for each segment.
Chapter 10: Latin America by Type, by Application and by country, sales, and revenue for each segment.
Chapter 11: Middle East and Africa by Type, by Application and by country, sales, and revenue for each segment.
Chapter 12: Analysis of industrial chain, sales channel, key raw materials, distributors, and customers.
Chapter 13: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 14: Research Findings and Conclusion.
1 Study Coverage
1.1 Hepatitis A Vaccine Product Introduction
1.2 Market by Type
1.2.1 Global Hepatitis A Vaccine Market Size Growth Rate by Type (2020 VS 2024 VS 2031)
1.2.2 Inactivated Vaccine
1.2.3 Live Attenuated Vaccine
1.3 Market by Application
1.3.1 Global Hepatitis A Vaccine Market Size Growth Rate by Application (2020 VS 2024 VS 2031)
1.3.2 Government Institution
1.3.3 Private Sector
1.3.4 Other
1.4 Study Objectives
1.5 Years Considered
2 Executive Summary
2.1 Global Hepatitis A Vaccine Market Size Estimates and Forecasts
2.1.1 Global Hepatitis A Vaccine Revenue 2020-2031
2.1.2 Global Hepatitis A Vaccine Sales 2020-2031
2.2 Hepatitis A Vaccine Market Size by Region: 2024 Versus 2031
2.3 Hepatitis A Vaccine Sales by Region (2020-2031)
2.3.1 Global Hepatitis A Vaccine Sales by Region: 2020-2025
2.3.2 Global Hepatitis A Vaccine Sales Forecast by Region (2026-2031)
2.3.3 Global Hepatitis A Vaccine Sales Market Share by Region (2020-2031)
2.4 Hepatitis A Vaccine Market Estimates and Projections by Region (2026-2031)
2.4.1 Global Hepatitis A Vaccine Revenue by Region: 2020-2025
2.4.2 Global Hepatitis A Vaccine Revenue Forecast by Region (2026-2031)
2.4.3 Global Hepatitis A Vaccine Revenue Market Share by Region (2020-2031)
3 Market Segments
3.1 Breakdown Data by Type
3.1.1 Global Hepatitis A Vaccine Sales by Type (2020-2031)
3.1.1.1 Global Hepatitis A Vaccine Sales Volume by Type (2020-2031)
3.1.1.2 Global Hepatitis A Vaccine Sales Market Share by Type (2020-2031)
3.1.2 Global Hepatitis A Vaccine Revenue by Type (2020-2031)
3.1.2.1 Global Hepatitis A Vaccine Revenue by Type (2020-2031)
3.1.2.2 Global Hepatitis A Vaccine Revenue Market Share by Type (2020-2031)
3.1.3 Hepatitis A Vaccine Average Selling Price (ASP) by Type (2020-2031)
3.2 Breakdown Data by Application
3.2.1 Global Hepatitis A Vaccine Sales by Application (2020-2031)
3.2.1.1 Global Hepatitis A Vaccine Sales Volume by Application (2020-2031)
3.2.1.2 Global Hepatitis A Vaccine Sales Market Share by Application (2020-2031)
3.2.2 Global Hepatitis A Vaccine Revenue by Application (2020-2031)
3.2.2.1 Global Hepatitis A Vaccine Revenue by Application (2020-2031)
3.2.2.2 Global Hepatitis A Vaccine Revenue Market Share by Application (2020-2031)
3.2.3 Hepatitis A Vaccine Average Selling Price (ASP) by Application (2020-2031)
3.3 by Type and by Application Crossing Analysis
3.3.1 Inactivated Vaccine of Hepatitis A Vaccine Revenue Market Share by Application
3.3.2 Live Attenuated Vaccine of Hepatitis A Vaccine Revenue Market Share by Application
4 Global Hepatitis A Vaccine by Manufacturers
4.1 Global Top Hepatitis A Vaccine Manufacturers by Sales (2020-2025)
4.1.1 Global Hepatitis A Vaccine Sales by Manufacturer (2020-2025)
4.1.2 Global Hepatitis A Vaccine Sales Market Share by Manufacturer (2020-2025)
4.2 Global Top Hepatitis A Vaccine Manufacturers by Revenue (2020-2025)
4.2.1 Global Hepatitis A Vaccine Revenue by Manufacturer (2020-2025)
4.2.2 Global Hepatitis A Vaccine Revenue Share by Manufacturer (2020-2025)
4.3 Global Hepatitis A Vaccine Price by Manufacturer (2020-2025)
4.4 Competitive Landscape
4.4.1 Key Hepatitis A Vaccine Manufacturers Covered: Ranking by Revenue
4.4.2 Global Hepatitis A Vaccine Market Concentration Ratio (CR5 and HHI) & (2020-2025)
4.4.3 Global Hepatitis A Vaccine Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
4.5 Global Hepatitis A Vaccine Manufacturing Base Distribution, Product Type
4.5.1 Hepatitis A Vaccine Manufacturers Manufacturing Base Distribution, Headquarters
4.5.2 Date of International Manufacturers Enter into Hepatitis A Vaccine Market
4.5.3 Manufacturers Hepatitis A Vaccine Product Type and Application
4.5.4 Inactivated Vaccine Market Sales of Hepatitis A Vaccine by Manufacturer
4.5.5 Live Attenuated Vaccine Market Sales of Hepatitis A Vaccine by Manufacturer
4.6 Manufacturers Mergers & Acquisitions, Expansion Plans
5 Company Profiles
5.1 GSK
5.1.1 GSK Company Information
5.1.2 GSK Description, Business Overview
5.1.3 GSK Hepatitis A Vaccine Products Offered
5.1.4 GSK Hepatitis A Vaccine Sales, Revenue and Gross Margin (2020-2025)
5.1.5 GSK Hepatitis A Vaccine Sales by Product in 2024
5.1.6 GSK Hepatitis A Vaccine Sales by Application in 2024
5.1.7 GSK Hepatitis A Vaccine Sales by Geographic Area in 2024
5.1.8 GSK Recent Developments
5.2 Merck
5.2.1 Merck Company Information
5.2.2 Merck Description, Business Overview
5.2.3 Merck Hepatitis A Vaccine Products Offered
5.2.4 Merck Hepatitis A Vaccine Sales, Revenue and Gross Margin (2020-2025)
5.2.5 Merck Hepatitis A Vaccine Sales by Product in 2024
5.2.6 Merck Hepatitis A Vaccine Sales by Application in 2024
5.2.7 Merck Hepatitis A Vaccine Sales by Geographic Area in 2024
5.2.8 Merck Recent Developments
5.3 Sanofi
5.3.1 Sanofi Company Information
5.3.2 Sanofi Description, Business Overview
5.3.3 Sanofi Hepatitis A Vaccine Products Offered
5.3.4 Sanofi Hepatitis A Vaccine Sales, Revenue and Gross Margin (2020-2025)
5.3.5 Sanofi Hepatitis A Vaccine Sales by Product in 2024
5.3.6 Sanofi Hepatitis A Vaccine Sales by Application in 2024
5.3.7 Sanofi Hepatitis A Vaccine Sales by Geographic Area in 2024
5.3.8 Sanofi Recent Developments
5.4 Sinovac
5.4.1 Sinovac Company Information
5.4.2 Sinovac Description, Business Overview
5.4.3 Sinovac Hepatitis A Vaccine Products Offered
5.4.4 Sinovac Hepatitis A Vaccine Sales, Revenue and Gross Margin (2020-2025)
5.4.5 Sinovac Hepatitis A Vaccine Sales by Product in 2024
5.4.6 Sinovac Hepatitis A Vaccine Sales by Application in 2024
5.4.7 Sinovac Hepatitis A Vaccine Sales by Geographic Area in 2024
5.4.8 Sinovac Recent Developments
5.5 Zhejiang Pukang
5.5.1 Zhejiang Pukang Company Information
5.5.2 Zhejiang Pukang Description, Business Overview
5.5.3 Zhejiang Pukang Hepatitis A Vaccine Products Offered
5.5.4 Zhejiang Pukang Hepatitis A Vaccine Sales, Revenue and Gross Margin (2020-2025)
5.5.5 Zhejiang Pukang Hepatitis A Vaccine Sales by Product in 2024
5.5.6 Zhejiang Pukang Hepatitis A Vaccine Sales by Application in 2024
5.5.7 Zhejiang Pukang Hepatitis A Vaccine Sales by Geographic Area in 2024
5.5.8 Zhejiang Pukang Recent Developments
5.6 Changchun Institute of Biological
5.6.1 Changchun Institute of Biological Company Information
5.6.2 Changchun Institute of Biological Description, Business Overview
5.6.3 Changchun Institute of Biological Hepatitis A Vaccine Products Offered
5.6.4 Changchun Institute of Biological Hepatitis A Vaccine Sales, Revenue and Gross Margin (2020-2025)
5.6.5 Changchun Institute of Biological Hepatitis A Vaccine Sales by Product in 2024
5.6.6 Changchun Institute of Biological Hepatitis A Vaccine Sales by Application in 2024
5.6.7 Changchun Institute of Biological Hepatitis A Vaccine Sales by Geographic Area in 2024
5.6.8 Changchun Institute of Biological Recent Developments
5.7 KM Biologics
5.7.1 KM Biologics Company Information
5.7.2 KM Biologics Description, Business Overview
5.7.3 KM Biologics Hepatitis A Vaccine Products Offered
5.7.4 KM Biologics Hepatitis A Vaccine Sales, Revenue and Gross Margin (2020-2025)
5.7.5 KM Biologics Hepatitis A Vaccine Sales by Product in 2024
5.7.6 KM Biologics Hepatitis A Vaccine Sales by Application in 2024
5.7.7 KM Biologics Hepatitis A Vaccine Sales by Geographic Area in 2024
5.7.8 KM Biologics Recent Developments
5.8 IMBCAMS
5.8.1 IMBCAMS Company Information
5.8.2 IMBCAMS Description, Business Overview
5.8.3 IMBCAMS Hepatitis A Vaccine Products Offered
5.8.4 IMBCAMS Hepatitis A Vaccine Sales, Revenue and Gross Margin (2020-2025)
5.8.5 IMBCAMS Hepatitis A Vaccine Sales by Product in 2024
5.8.6 IMBCAMS Hepatitis A Vaccine Sales by Application in 2024
5.8.7 IMBCAMS Hepatitis A Vaccine Sales by Geographic Area in 2024
5.8.8 IMBCAMS Recent Developments
5.9 Convac
5.9.1 Convac Company Information
5.9.2 Convac Description, Business Overview
5.9.3 Convac Hepatitis A Vaccine Products Offered
5.9.4 Convac Hepatitis A Vaccine Sales, Revenue and Gross Margin (2020-2025)
5.9.5 Convac Hepatitis A Vaccine Sales by Product in 2024
5.9.6 Convac Hepatitis A Vaccine Sales by Application in 2024
5.9.7 Convac Hepatitis A Vaccine Sales by Geographic Area in 2024
5.9.8 Convac Recent Developments
6 North America
6.1 North America Hepatitis A Vaccine Market Size YoY Growth 2020-2031
6.2 North America Hepatitis A Vaccine Market Facts & Figures by Country
6.2.1 North America Hepatitis A Vaccine Sales by Country (2020-2031)
6.2.2 North America Hepatitis A Vaccine Revenue by Country (2020-2031)
6.3 North America Hepatitis A Vaccine Sales by Type (2020-2025)
6.4 North America Hepatitis A Vaccine Sales by Application (2020-2025)
7 Asia-Pacific
7.1 Asia-Pacific Hepatitis A Vaccine Market Size YoY Growth 2020-2031
7.2 Asia-Pacific Hepatitis A Vaccine Market Facts & Figures by Region
7.2.1 Asia-Pacific Hepatitis A Vaccine Sales by Region (2020-2031)
7.2.2 Asia-Pacific Hepatitis A Vaccine Revenue by Region (2020-2031)
7.3 Asia-Pacific Hepatitis A Vaccine Sales by Type (2020-2025)
7.4 Asia-Pacific Hepatitis A Vaccine Sales by Application (2020-2025)
8 Europe
8.1 Europe Hepatitis A Vaccine Market Size YoY Growth 2020-2031
8.2 Europe Hepatitis A Vaccine Market Facts & Figures by Country
8.2.1 Europe Hepatitis A Vaccine Sales by Country (2020-2031)
8.2.2 Europe Hepatitis A Vaccine Revenue by Country (2020-2031)
8.3 Europe Hepatitis A Vaccine Sales by Type (2020-2025)
8.4 Europe Hepatitis A Vaccine Sales by Application (2020-2025)
9 Latin America
9.1 Latin America Hepatitis A Vaccine Market Size YoY Growth 2020-2031
9.2 Latin America Hepatitis A Vaccine Market Facts & Figures by Country
9.2.1 Latin America Hepatitis A Vaccine Sales by Country (2020-2031)
9.2.2 Latin America Hepatitis A Vaccine Revenue by Country (2020-2031)
9.3 Latin America Hepatitis A Vaccine Sales by Type (2020-2025)
9.4 Latin America Hepatitis A Vaccine Sales by Application (2020-2025)
10 Middle East and Africa
10.1 Latin America Hepatitis A Vaccine Market Size YoY Growth 2020-2031
10.2 Middle East and Africa Hepatitis A Vaccine Market Facts & Figures by Country
10.2.1 Middle East and Africa Hepatitis A Vaccine Sales by Country (2020-2031)
10.2.2 Middle East and Africa Hepatitis A Vaccine Revenue by Country (2020-2031)
10.3 Middle East and Africa Hepatitis A Vaccine Sales by Type (2020-2025)
10.4 Middle East and Africa Hepatitis A Vaccine Sales by Application (2020-2025)
11 Supply Chain and Sales Channel analysis
11.1 Hepatitis A Vaccine Supply Chain Analysis
11.2 Hepatitis A Vaccine Key Raw Materials and Upstream Suppliers
11.3 Hepatitis A Vaccine Clients Analysis
11.4 Hepatitis A Vaccine Sales Channel and Sales Model Analysis
11.4.1 Hepatitis A Vaccine Distribution Channel Analysis: Indirect Sales VS Direct Sales
11.4.2 Hepatitis A Vaccine Distribution Channel Analysis: Online Sales VS Offline Sales
11.4.3 Hepatitis A Vaccine Distributors
12 Hepatitis A Vaccine Market Dynamics
12.1 Hepatitis A Vaccine Industry Trends
12.2 Hepatitis A Vaccine Market Drivers
12.3 Hepatitis A Vaccine Market Challenges
12.4 Hepatitis A Vaccine Market Restraints
13 Research Findings and Conclusion
14 Appendix
14.1 Research Methodology
14.1.1 Methodology/Research Approach
14.1.1.1 Research Programs/Design
14.1.1.2 Market Size Estimation
14.1.1.3 Market Breakdown and Data Triangulation
14.1.2 Data Source
14.1.2.1 Secondary Sources
14.1.2.2 Primary Sources
14.2 Author Details
14.3 Disclaimer
1.1 Hepatitis A Vaccine Product Introduction
1.2 Market by Type
1.2.1 Global Hepatitis A Vaccine Market Size Growth Rate by Type (2020 VS 2024 VS 2031)
1.2.2 Inactivated Vaccine
1.2.3 Live Attenuated Vaccine
1.3 Market by Application
1.3.1 Global Hepatitis A Vaccine Market Size Growth Rate by Application (2020 VS 2024 VS 2031)
1.3.2 Government Institution
1.3.3 Private Sector
1.3.4 Other
1.4 Study Objectives
1.5 Years Considered
2 Executive Summary
2.1 Global Hepatitis A Vaccine Market Size Estimates and Forecasts
2.1.1 Global Hepatitis A Vaccine Revenue 2020-2031
2.1.2 Global Hepatitis A Vaccine Sales 2020-2031
2.2 Hepatitis A Vaccine Market Size by Region: 2024 Versus 2031
2.3 Hepatitis A Vaccine Sales by Region (2020-2031)
2.3.1 Global Hepatitis A Vaccine Sales by Region: 2020-2025
2.3.2 Global Hepatitis A Vaccine Sales Forecast by Region (2026-2031)
2.3.3 Global Hepatitis A Vaccine Sales Market Share by Region (2020-2031)
2.4 Hepatitis A Vaccine Market Estimates and Projections by Region (2026-2031)
2.4.1 Global Hepatitis A Vaccine Revenue by Region: 2020-2025
2.4.2 Global Hepatitis A Vaccine Revenue Forecast by Region (2026-2031)
2.4.3 Global Hepatitis A Vaccine Revenue Market Share by Region (2020-2031)
3 Market Segments
3.1 Breakdown Data by Type
3.1.1 Global Hepatitis A Vaccine Sales by Type (2020-2031)
3.1.1.1 Global Hepatitis A Vaccine Sales Volume by Type (2020-2031)
3.1.1.2 Global Hepatitis A Vaccine Sales Market Share by Type (2020-2031)
3.1.2 Global Hepatitis A Vaccine Revenue by Type (2020-2031)
3.1.2.1 Global Hepatitis A Vaccine Revenue by Type (2020-2031)
3.1.2.2 Global Hepatitis A Vaccine Revenue Market Share by Type (2020-2031)
3.1.3 Hepatitis A Vaccine Average Selling Price (ASP) by Type (2020-2031)
3.2 Breakdown Data by Application
3.2.1 Global Hepatitis A Vaccine Sales by Application (2020-2031)
3.2.1.1 Global Hepatitis A Vaccine Sales Volume by Application (2020-2031)
3.2.1.2 Global Hepatitis A Vaccine Sales Market Share by Application (2020-2031)
3.2.2 Global Hepatitis A Vaccine Revenue by Application (2020-2031)
3.2.2.1 Global Hepatitis A Vaccine Revenue by Application (2020-2031)
3.2.2.2 Global Hepatitis A Vaccine Revenue Market Share by Application (2020-2031)
3.2.3 Hepatitis A Vaccine Average Selling Price (ASP) by Application (2020-2031)
3.3 by Type and by Application Crossing Analysis
3.3.1 Inactivated Vaccine of Hepatitis A Vaccine Revenue Market Share by Application
3.3.2 Live Attenuated Vaccine of Hepatitis A Vaccine Revenue Market Share by Application
4 Global Hepatitis A Vaccine by Manufacturers
4.1 Global Top Hepatitis A Vaccine Manufacturers by Sales (2020-2025)
4.1.1 Global Hepatitis A Vaccine Sales by Manufacturer (2020-2025)
4.1.2 Global Hepatitis A Vaccine Sales Market Share by Manufacturer (2020-2025)
4.2 Global Top Hepatitis A Vaccine Manufacturers by Revenue (2020-2025)
4.2.1 Global Hepatitis A Vaccine Revenue by Manufacturer (2020-2025)
4.2.2 Global Hepatitis A Vaccine Revenue Share by Manufacturer (2020-2025)
4.3 Global Hepatitis A Vaccine Price by Manufacturer (2020-2025)
4.4 Competitive Landscape
4.4.1 Key Hepatitis A Vaccine Manufacturers Covered: Ranking by Revenue
4.4.2 Global Hepatitis A Vaccine Market Concentration Ratio (CR5 and HHI) & (2020-2025)
4.4.3 Global Hepatitis A Vaccine Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
4.5 Global Hepatitis A Vaccine Manufacturing Base Distribution, Product Type
4.5.1 Hepatitis A Vaccine Manufacturers Manufacturing Base Distribution, Headquarters
4.5.2 Date of International Manufacturers Enter into Hepatitis A Vaccine Market
4.5.3 Manufacturers Hepatitis A Vaccine Product Type and Application
4.5.4 Inactivated Vaccine Market Sales of Hepatitis A Vaccine by Manufacturer
4.5.5 Live Attenuated Vaccine Market Sales of Hepatitis A Vaccine by Manufacturer
4.6 Manufacturers Mergers & Acquisitions, Expansion Plans
5 Company Profiles
5.1 GSK
5.1.1 GSK Company Information
5.1.2 GSK Description, Business Overview
5.1.3 GSK Hepatitis A Vaccine Products Offered
5.1.4 GSK Hepatitis A Vaccine Sales, Revenue and Gross Margin (2020-2025)
5.1.5 GSK Hepatitis A Vaccine Sales by Product in 2024
5.1.6 GSK Hepatitis A Vaccine Sales by Application in 2024
5.1.7 GSK Hepatitis A Vaccine Sales by Geographic Area in 2024
5.1.8 GSK Recent Developments
5.2 Merck
5.2.1 Merck Company Information
5.2.2 Merck Description, Business Overview
5.2.3 Merck Hepatitis A Vaccine Products Offered
5.2.4 Merck Hepatitis A Vaccine Sales, Revenue and Gross Margin (2020-2025)
5.2.5 Merck Hepatitis A Vaccine Sales by Product in 2024
5.2.6 Merck Hepatitis A Vaccine Sales by Application in 2024
5.2.7 Merck Hepatitis A Vaccine Sales by Geographic Area in 2024
5.2.8 Merck Recent Developments
5.3 Sanofi
5.3.1 Sanofi Company Information
5.3.2 Sanofi Description, Business Overview
5.3.3 Sanofi Hepatitis A Vaccine Products Offered
5.3.4 Sanofi Hepatitis A Vaccine Sales, Revenue and Gross Margin (2020-2025)
5.3.5 Sanofi Hepatitis A Vaccine Sales by Product in 2024
5.3.6 Sanofi Hepatitis A Vaccine Sales by Application in 2024
5.3.7 Sanofi Hepatitis A Vaccine Sales by Geographic Area in 2024
5.3.8 Sanofi Recent Developments
5.4 Sinovac
5.4.1 Sinovac Company Information
5.4.2 Sinovac Description, Business Overview
5.4.3 Sinovac Hepatitis A Vaccine Products Offered
5.4.4 Sinovac Hepatitis A Vaccine Sales, Revenue and Gross Margin (2020-2025)
5.4.5 Sinovac Hepatitis A Vaccine Sales by Product in 2024
5.4.6 Sinovac Hepatitis A Vaccine Sales by Application in 2024
5.4.7 Sinovac Hepatitis A Vaccine Sales by Geographic Area in 2024
5.4.8 Sinovac Recent Developments
5.5 Zhejiang Pukang
5.5.1 Zhejiang Pukang Company Information
5.5.2 Zhejiang Pukang Description, Business Overview
5.5.3 Zhejiang Pukang Hepatitis A Vaccine Products Offered
5.5.4 Zhejiang Pukang Hepatitis A Vaccine Sales, Revenue and Gross Margin (2020-2025)
5.5.5 Zhejiang Pukang Hepatitis A Vaccine Sales by Product in 2024
5.5.6 Zhejiang Pukang Hepatitis A Vaccine Sales by Application in 2024
5.5.7 Zhejiang Pukang Hepatitis A Vaccine Sales by Geographic Area in 2024
5.5.8 Zhejiang Pukang Recent Developments
5.6 Changchun Institute of Biological
5.6.1 Changchun Institute of Biological Company Information
5.6.2 Changchun Institute of Biological Description, Business Overview
5.6.3 Changchun Institute of Biological Hepatitis A Vaccine Products Offered
5.6.4 Changchun Institute of Biological Hepatitis A Vaccine Sales, Revenue and Gross Margin (2020-2025)
5.6.5 Changchun Institute of Biological Hepatitis A Vaccine Sales by Product in 2024
5.6.6 Changchun Institute of Biological Hepatitis A Vaccine Sales by Application in 2024
5.6.7 Changchun Institute of Biological Hepatitis A Vaccine Sales by Geographic Area in 2024
5.6.8 Changchun Institute of Biological Recent Developments
5.7 KM Biologics
5.7.1 KM Biologics Company Information
5.7.2 KM Biologics Description, Business Overview
5.7.3 KM Biologics Hepatitis A Vaccine Products Offered
5.7.4 KM Biologics Hepatitis A Vaccine Sales, Revenue and Gross Margin (2020-2025)
5.7.5 KM Biologics Hepatitis A Vaccine Sales by Product in 2024
5.7.6 KM Biologics Hepatitis A Vaccine Sales by Application in 2024
5.7.7 KM Biologics Hepatitis A Vaccine Sales by Geographic Area in 2024
5.7.8 KM Biologics Recent Developments
5.8 IMBCAMS
5.8.1 IMBCAMS Company Information
5.8.2 IMBCAMS Description, Business Overview
5.8.3 IMBCAMS Hepatitis A Vaccine Products Offered
5.8.4 IMBCAMS Hepatitis A Vaccine Sales, Revenue and Gross Margin (2020-2025)
5.8.5 IMBCAMS Hepatitis A Vaccine Sales by Product in 2024
5.8.6 IMBCAMS Hepatitis A Vaccine Sales by Application in 2024
5.8.7 IMBCAMS Hepatitis A Vaccine Sales by Geographic Area in 2024
5.8.8 IMBCAMS Recent Developments
5.9 Convac
5.9.1 Convac Company Information
5.9.2 Convac Description, Business Overview
5.9.3 Convac Hepatitis A Vaccine Products Offered
5.9.4 Convac Hepatitis A Vaccine Sales, Revenue and Gross Margin (2020-2025)
5.9.5 Convac Hepatitis A Vaccine Sales by Product in 2024
5.9.6 Convac Hepatitis A Vaccine Sales by Application in 2024
5.9.7 Convac Hepatitis A Vaccine Sales by Geographic Area in 2024
5.9.8 Convac Recent Developments
6 North America
6.1 North America Hepatitis A Vaccine Market Size YoY Growth 2020-2031
6.2 North America Hepatitis A Vaccine Market Facts & Figures by Country
6.2.1 North America Hepatitis A Vaccine Sales by Country (2020-2031)
6.2.2 North America Hepatitis A Vaccine Revenue by Country (2020-2031)
6.3 North America Hepatitis A Vaccine Sales by Type (2020-2025)
6.4 North America Hepatitis A Vaccine Sales by Application (2020-2025)
7 Asia-Pacific
7.1 Asia-Pacific Hepatitis A Vaccine Market Size YoY Growth 2020-2031
7.2 Asia-Pacific Hepatitis A Vaccine Market Facts & Figures by Region
7.2.1 Asia-Pacific Hepatitis A Vaccine Sales by Region (2020-2031)
7.2.2 Asia-Pacific Hepatitis A Vaccine Revenue by Region (2020-2031)
7.3 Asia-Pacific Hepatitis A Vaccine Sales by Type (2020-2025)
7.4 Asia-Pacific Hepatitis A Vaccine Sales by Application (2020-2025)
8 Europe
8.1 Europe Hepatitis A Vaccine Market Size YoY Growth 2020-2031
8.2 Europe Hepatitis A Vaccine Market Facts & Figures by Country
8.2.1 Europe Hepatitis A Vaccine Sales by Country (2020-2031)
8.2.2 Europe Hepatitis A Vaccine Revenue by Country (2020-2031)
8.3 Europe Hepatitis A Vaccine Sales by Type (2020-2025)
8.4 Europe Hepatitis A Vaccine Sales by Application (2020-2025)
9 Latin America
9.1 Latin America Hepatitis A Vaccine Market Size YoY Growth 2020-2031
9.2 Latin America Hepatitis A Vaccine Market Facts & Figures by Country
9.2.1 Latin America Hepatitis A Vaccine Sales by Country (2020-2031)
9.2.2 Latin America Hepatitis A Vaccine Revenue by Country (2020-2031)
9.3 Latin America Hepatitis A Vaccine Sales by Type (2020-2025)
9.4 Latin America Hepatitis A Vaccine Sales by Application (2020-2025)
10 Middle East and Africa
10.1 Latin America Hepatitis A Vaccine Market Size YoY Growth 2020-2031
10.2 Middle East and Africa Hepatitis A Vaccine Market Facts & Figures by Country
10.2.1 Middle East and Africa Hepatitis A Vaccine Sales by Country (2020-2031)
10.2.2 Middle East and Africa Hepatitis A Vaccine Revenue by Country (2020-2031)
10.3 Middle East and Africa Hepatitis A Vaccine Sales by Type (2020-2025)
10.4 Middle East and Africa Hepatitis A Vaccine Sales by Application (2020-2025)
11 Supply Chain and Sales Channel analysis
11.1 Hepatitis A Vaccine Supply Chain Analysis
11.2 Hepatitis A Vaccine Key Raw Materials and Upstream Suppliers
11.3 Hepatitis A Vaccine Clients Analysis
11.4 Hepatitis A Vaccine Sales Channel and Sales Model Analysis
11.4.1 Hepatitis A Vaccine Distribution Channel Analysis: Indirect Sales VS Direct Sales
11.4.2 Hepatitis A Vaccine Distribution Channel Analysis: Online Sales VS Offline Sales
11.4.3 Hepatitis A Vaccine Distributors
12 Hepatitis A Vaccine Market Dynamics
12.1 Hepatitis A Vaccine Industry Trends
12.2 Hepatitis A Vaccine Market Drivers
12.3 Hepatitis A Vaccine Market Challenges
12.4 Hepatitis A Vaccine Market Restraints
13 Research Findings and Conclusion
14 Appendix
14.1 Research Methodology
14.1.1 Methodology/Research Approach
14.1.1.1 Research Programs/Design
14.1.1.2 Market Size Estimation
14.1.1.3 Market Breakdown and Data Triangulation
14.1.2 Data Source
14.1.2.1 Secondary Sources
14.1.2.2 Primary Sources
14.2 Author Details
14.3 Disclaimer
List of Tables
Table 1. Global Hepatitis A Vaccine Market Size Growth Rate by Type (US$ Million): 2020 VS 2024 VS 2031
Table 2. Global Hepatitis A Vaccine Market Size Growth by Application (US$ Million): 2020 VS 2024 VS 2031
Table 3. Global Hepatitis A Vaccine Market Size by Region (US$ Million): 2024 VS 2031
Table 4. Global Hepatitis A Vaccine Sales by Region (2020-2025) & (K Unit)
Table 5. Global Hepatitis A Vaccine Sales Forecast by Region (2026-2031) & (K Unit)
Table 6. Global Hepatitis A Vaccine Revenue by Region (2020-2025) & (US$ Million)
Table 7. Global Hepatitis A Vaccine Revenue Forecast by Region (2026-2031) & (US$ Million)
Table 8. Global Hepatitis A Vaccine Sales Volume by Type (2020-2025) & (K Unit)
Table 9. Global Hepatitis A Vaccine Sales Volume by Type (2026-2031) & (K Unit)
Table 10. Global Hepatitis A Vaccine Revenue by Type (2020-2025) & (US$ Million)
Table 11. Global Hepatitis A Vaccine Revenue Forecast by Type (2026-2031) & (US$ Million)
Table 12. Global Hepatitis A Vaccine Sales Volume by Application (2020-2025) & (K Unit)
Table 13. Global Hepatitis A Vaccine Sales Volume by Application (2026-2031) & (K Unit)
Table 14. Global Hepatitis A Vaccine Revenue by Application (2020-2025) & (US$ Million)
Table 15. Global Hepatitis A Vaccine Revenue by Application (2026-2031) & (US$ Million)
Table 16. Global Hepatitis A Vaccine Sales by Manufacturer (2020-2025) & (K Unit)
Table 17. Global Hepatitis A Vaccine Sales Share by Manufacturer (2020-2025)
Table 18. Hepatitis A Vaccine Revenue by Manufacturer (2020-2025) & (US$ Million)
Table 19. Hepatitis A Vaccine Revenue Share by Manufacturer (2020-2025)
Table 20. Key Manufacturers Hepatitis A Vaccine Price (2020-2025) & (USD/Unit)
Table 21. Ranking of Global Top Hepatitis A Vaccine Manufacturers by Revenue (US$ Million) in 2024
Table 22. Global Hepatitis A Vaccine Manufacturers Market Concentration Ratio (CR5 and HHI) & (2020-2025)
Table 23. Global Hepatitis A Vaccine by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Hepatitis A Vaccine as of 2024)
Table 24. Hepatitis A Vaccine Manufacturers Manufacturing Base Distribution and Headquarters
Table 25. Date of International Manufacturers Enter into Hepatitis A Vaccine Market
Table 26. Manufacturers Hepatitis A Vaccine Product Type and Application
Table 27. Manufacturers Mergers & Acquisitions, Expansion Plans
Table 28. GSK Company Information
Table 29. GSK Description and Business Overview
Table 30. GSK Hepatitis A Vaccine Product
Table 31. GSK Hepatitis A Vaccine Sales (K Unit), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)
Table 32. GSK Sales Proportion of Hepatitis A Vaccine by Product in 2024
Table 33. GSK Sales Proportion of Hepatitis A Vaccine by Application in 2024
Table 34. GSK Sales Proportion of Hepatitis A Vaccine by Geographic Area in 2024
Table 35. GSK Recent Developments
Table 36. Merck Company Information
Table 37. Merck Description and Business Overview
Table 38. Merck Hepatitis A Vaccine Product
Table 39. Merck Hepatitis A Vaccine Sales (K Unit), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)
Table 40. Merck Sales Proportion of Hepatitis A Vaccine by Product in 2024
Table 41. Merck Sales Proportion of Hepatitis A Vaccine by Application in 2024
Table 42. Merck Sales Proportion of Hepatitis A Vaccine by Geographic Area in 2024
Table 43. Merck Recent Developments
Table 44. Sanofi Company Information
Table 45. Sanofi Description and Business Overview
Table 46. Sanofi Hepatitis A Vaccine Product
Table 47. Sanofi Hepatitis A Vaccine Sales (K Unit), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)
Table 48. Sanofi Sales Proportion of Hepatitis A Vaccine by Product in 2024
Table 49. Sanofi Sales Proportion of Hepatitis A Vaccine by Application in 2024
Table 50. Sanofi Sales Proportion of Hepatitis A Vaccine by Geographic Area in 2024
Table 51. Sanofi Recent Developments
Table 52. Sinovac Company Information
Table 53. Sinovac Description and Business Overview
Table 54. Sinovac Hepatitis A Vaccine Product
Table 55. Sinovac Hepatitis A Vaccine Sales (K Unit), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)
Table 56. Sinovac Sales Proportion of Hepatitis A Vaccine by Product in 2024
Table 57. Sinovac Sales Proportion of Hepatitis A Vaccine by Application in 2024
Table 58. Sinovac Sales Proportion of Hepatitis A Vaccine by Geographic Area in 2024
Table 59. Sinovac Recent Developments
Table 60. Zhejiang Pukang Company Information
Table 61. Zhejiang Pukang Description and Business Overview
Table 62. Zhejiang Pukang Hepatitis A Vaccine Product
Table 63. Zhejiang Pukang Hepatitis A Vaccine Sales (K Unit), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)
Table 64. Zhejiang Pukang Sales Proportion of Hepatitis A Vaccine by Product in 2024
Table 65. Zhejiang Pukang Sales Proportion of Hepatitis A Vaccine by Application in 2024
Table 66. Zhejiang Pukang Sales Proportion of Hepatitis A Vaccine by Geographic Area in 2024
Table 67. Zhejiang Pukang Recent Developments
Table 68. Changchun Institute of Biological Company Information
Table 69. Changchun Institute of Biological Description and Business Overview
Table 70. Changchun Institute of Biological Hepatitis A Vaccine Product
Table 71. Changchun Institute of Biological Hepatitis A Vaccine Sales (K Unit), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)
Table 72. Changchun Institute of Biological Sales Proportion of Hepatitis A Vaccine by Product in 2024
Table 73. Changchun Institute of Biological Sales Proportion of Hepatitis A Vaccine by Application in 2024
Table 74. Changchun Institute of Biological Sales Proportion of Hepatitis A Vaccine by Geographic Area in 2024
Table 75. Changchun Institute of Biological Recent Developments
Table 76. KM Biologics Company Information
Table 77. KM Biologics Description and Business Overview
Table 78. KM Biologics Hepatitis A Vaccine Product
Table 79. KM Biologics Hepatitis A Vaccine Sales (K Unit), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)
Table 80. KM Biologics Sales Proportion of Hepatitis A Vaccine by Product in 2024
Table 81. KM Biologics Sales Proportion of Hepatitis A Vaccine by Application in 2024
Table 82. KM Biologics Sales Proportion of Hepatitis A Vaccine by Geographic Area in 2024
Table 83. KM Biologics Recent Developments
Table 84. IMBCAMS Company Information
Table 85. IMBCAMS Description and Business Overview
Table 86. IMBCAMS Hepatitis A Vaccine Product
Table 87. IMBCAMS Hepatitis A Vaccine Sales (K Unit), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)
Table 88. IMBCAMS Sales Proportion of Hepatitis A Vaccine by Product in 2024
Table 89. IMBCAMS Sales Proportion of Hepatitis A Vaccine by Application in 2024
Table 90. IMBCAMS Sales Proportion of Hepatitis A Vaccine by Geographic Area in 2024
Table 91. IMBCAMS Recent Developments
Table 92. Convac Company Information
Table 93. Convac Description and Business Overview
Table 94. Convac Hepatitis A Vaccine Product
Table 95. Convac Hepatitis A Vaccine Sales (K Unit), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)
Table 96. Convac Sales Proportion of Hepatitis A Vaccine by Product in 2024
Table 97. Convac Sales Proportion of Hepatitis A Vaccine by Application in 2024
Table 98. Convac Sales Proportion of Hepatitis A Vaccine by Geographic Area in 2024
Table 99. Convac Recent Developments
Table 100. North America Hepatitis A Vaccine Sales by Country (2020-2025) & (K Unit)
Table 101. North America Hepatitis A Vaccine Sales by Country (2026-2031) & (K Unit)
Table 102. North America Hepatitis A Vaccine Revenue by Country (2020-2025) & (US$ Million)
Table 103. North America Hepatitis A Vaccine Revenue by Country (2026-2031) & (US$ Million)
Table 104. North America Hepatitis A Vaccine Sales by Type (2020-2025) & (K Unit)
Table 105. North America Hepatitis A Vaccine Sales by Application (2020-2025) & (K Unit)
Table 106. Asia-Pacific Hepatitis A Vaccine Sales by Region (2020-2025) & (K Unit)
Table 107. Asia-Pacific Hepatitis A Vaccine Sales by Region (2026-2031) & (K Unit)
Table 108. Asia-Pacific Hepatitis A Vaccine Revenue by Region (2020-2025) & (US$ Million)
Table 109. Asia-Pacific Hepatitis A Vaccine Revenue by Region (2026-2031) & (US$ Million)
Table 110. Asia-Pacific Hepatitis A Vaccine Sales by Type (2020-2025) & (K Unit)
Table 111. Asia-Pacific Hepatitis A Vaccine Sales by Application (2020-2025) & (K Unit)
Table 112. Europe Hepatitis A Vaccine Sales by Country (2020-2025) & (K Unit)
Table 113. Europe Hepatitis A Vaccine Sales by Country (2026-2031) & (K Unit)
Table 114. Europe Hepatitis A Vaccine Revenue by Country (2020-2025) & (US$ Million)
Table 115. Europe Hepatitis A Vaccine Revenue by Country (2026-2031) & (US$ Million)
Table 116. Europe Hepatitis A Vaccine Sales by Type (2020-2025) & (K Unit)
Table 117. Europe Hepatitis A Vaccine Sales by Application (2020-2025) & (K Unit)
Table 118. Latin America Hepatitis A Vaccine Sales by Country (2020-2025) & (K Unit)
Table 119. Latin America Hepatitis A Vaccine Sales by Country (2026-2031) & (K Unit)
Table 120. Latin America Hepatitis A Vaccine Revenue by Country (2020-2025) & (US$ Million)
Table 121. Latin America Hepatitis A Vaccine Revenue by Country (2026-2031) & (US$ Million)
Table 122. Latin America Hepatitis A Vaccine Sales by Type (2020-2025) & (K Unit)
Table 123. Latin America Hepatitis A Vaccine Sales by Application (2020-2025) & (K Unit)
Table 124. Middle East and Africa Hepatitis A Vaccine Sales by Country (2020-2025) & (K Unit)
Table 125. Middle East and Africa Hepatitis A Vaccine Sales by Country (2026-2031) & (K Unit)
Table 126. Middle East and Africa Hepatitis A Vaccine Revenue by Country (2020-2025) & (US$ Million)
Table 127. Middle East and Africa Hepatitis A Vaccine Revenue by Country (2026-2031) & (US$ Million)
Table 128. Middle East and Africa Hepatitis A Vaccine Sales by Type (2020-2025) & (K Unit)
Table 129. Middle East and Africa Hepatitis A Vaccine Sales by Application (2020-2025) & (K Unit)
Table 130. Hepatitis A Vaccine Key Raw Materials, Industry Status and Trend
Table 131. Hepatitis A Vaccine Key Raw Materials and Upstream Suppliers
Table 132. Hepatitis A Vaccine Clients Status and Trend
Table 133. Hepatitis A Vaccine Typical Clients
Table 134. Hepatitis A Vaccine Distributors
Table 135. Hepatitis A Vaccine Market Trends
Table 136. Hepatitis A Vaccine Market Drivers
Table 137. Hepatitis A Vaccine Market Challenges
Table 138. Hepatitis A Vaccine Market Restraints
Table 139. Research Programs/Design for This Report
Table 140. Key Data Information from Secondary Sources
Table 141. Key Data Information from Primary Sources
Table 142. QYR Business Unit and Senior & Team Lead Analysts
List of Figures
Figure 1. Hepatitis A Vaccine Product Picture
Figure 2. Global Hepatitis A Vaccine Market Size by Type (US$ Million): 2020 VS 2024 VS 2031
Figure 3. Global Hepatitis A Vaccine Sales Market Share by Type in 2024 & 2031
Figure 4. Inactivated Vaccine Product Picture
Figure 5. Live Attenuated Vaccine Product Picture
Figure 6. Global Hepatitis A Vaccine Market Size by Application (US$ Million): 2020 VS 2024 VS 2031
Figure 7. Global Hepatitis A Vaccine Sales Market Share by Application in 2024 & 2031
Figure 8. Government Institution
Figure 9. Private Sector
Figure 10. Other
Figure 11. Hepatitis A Vaccine Report Years Considered
Figure 12. Global Hepatitis A Vaccine Revenue, (US$ Million), 2020 VS 2024 VS 2031
Figure 13. Global Hepatitis A Vaccine Market Size 2020-2031 (US$ Million)
Figure 14. Global Hepatitis A Vaccine Sales 2020-2031 (K Unit)
Figure 15. Global Hepatitis A Vaccine Sales Market Share Forecast by Region (2020-2031)
Figure 16. Global Hepatitis A Vaccine Revenue Market Share by Region (2020-2031)
Figure 17. Global Hepatitis A Vaccine Sales Market Share Forecast by Type (2020-2031)
Figure 18. Global Hepatitis A Vaccine Revenue Market Share Forecast by Type (2020-2031)
Figure 19. Hepatitis A Vaccine Average Selling Price (ASP) by Type (2020-2025) & (USD/Unit)
Figure 20. Global Hepatitis A Vaccine Sales Market Share Forecast by Application (2020-2031)
Figure 21. Global Hepatitis A Vaccine Revenue Market Share Forecast by Application (2020-2031)
Figure 22. Hepatitis A Vaccine Average Selling Price (ASP) by Application (2020-2025) & (USD/Unit)
Figure 23. Inactivated Vaccine of Hepatitis A Vaccine Revenue Market Share by Application, 2024 VS 2031
Figure 24. Live Attenuated Vaccine of Hepatitis A Vaccine Revenue Market Share by Application, 2024 VS 2031
Figure 25. Global Hepatitis A Vaccine Sales Share by Manufacturer in 2024
Figure 26. Hepatitis A Vaccine Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2020 VS 2024
Figure 27. Inactivated Vaccine Market Sales Proportion by Manufacturer in 2024
Figure 28. Live Attenuated Vaccine Market Sales Proportion by Manufacturer in 2024
Figure 29. North America Hepatitis A Vaccine Revenue 2020-2031 (US$ Million)
Figure 30. North America Hepatitis A Vaccine Sales Market Share by Type (2020-2025)
Figure 31. North America Hepatitis A Vaccine Sales Market Share by Application (2020-2025)
Figure 32. Asia-Pacific Hepatitis A Vaccine Revenue 2020-2031 (US$ Million)
Figure 33. Asia-Pacific Hepatitis A Vaccine Sales Market Share by Region (2020-2031)
Figure 34. Asia-Pacific Hepatitis A Vaccine Revenue Market Share by Region (2020-2031)
Figure 35. Asia-Pacific Hepatitis A Vaccine Sales Market Share by Type (2020-2025)
Figure 36. Asia-Pacific Hepatitis A Vaccine Sales Market Share by Application (2020-2025)
Figure 37. Europe Hepatitis A Vaccine Revenue Growth Rate 2020-2031 (US$ Million)
Figure 38. Europe Hepatitis A Vaccine Sales Market Share by Country (2020-2031)
Figure 39. Europe Hepatitis A Vaccine Revenue Market Share by Country (2020-2031)
Figure 40. Europe Hepatitis A Vaccine Sales Market Share by Type (2020-2025)
Figure 41. Europe Hepatitis A Vaccine Sales Market Share by Application (2020-2025)
Figure 42. Latin America Hepatitis A Vaccine Revenue Growth Rate 2020-2031 (US$ Million)
Figure 43. Latin America Hepatitis A Vaccine Sales Market Share by Country (2020-2031)
Figure 44. Latin America Hepatitis A Vaccine Revenue Market Share by Country (2020-2025)
Figure 45. Latin America Hepatitis A Vaccine Sales Market Share by Type (2020-2025)
Figure 46. Latin America Hepatitis A Vaccine Sales Market Share by Application (2020-2025)
Figure 47. Middle East and Africa Hepatitis A Vaccine Revenue Growth Rate 2020-2031 (US$ Million)
Figure 48. Middle East and Africa Hepatitis A Vaccine Sales Market Share by Country (2020-2031)
Figure 49. Middle East and Africa Hepatitis A Vaccine Revenue Market Share by Country (2020-2031)
Figure 50. Middle East and Africa Hepatitis A Vaccine Sales Market Share by Type (2020-2025)
Figure 51. Middle East and Africa Hepatitis A Vaccine Sales Market Share by Application (2020-2025)
Figure 52. Hepatitis A Vaccine Supply Chain (Upstream and Downstream Market)
Figure 53. Global Production Market Share of Hepatitis A Vaccine Raw Materials by Region in 2024
Figure 54. Hepatitis A Vaccine Distribution Channels
Figure 55. Global Hepatitis A Vaccine Percentage 2020-2031: Indirect Sales VS Direct Sales
Figure 56. Global Hepatitis A Vaccine Percentage 2020-2031: Online Sales VS Offline Sales
Figure 57. Bottom-up and Top-down Approaches for This Report
Figure 58. Data Triangulation
Figure 59. Key Executives Interviewed
Table 1. Global Hepatitis A Vaccine Market Size Growth Rate by Type (US$ Million): 2020 VS 2024 VS 2031
Table 2. Global Hepatitis A Vaccine Market Size Growth by Application (US$ Million): 2020 VS 2024 VS 2031
Table 3. Global Hepatitis A Vaccine Market Size by Region (US$ Million): 2024 VS 2031
Table 4. Global Hepatitis A Vaccine Sales by Region (2020-2025) & (K Unit)
Table 5. Global Hepatitis A Vaccine Sales Forecast by Region (2026-2031) & (K Unit)
Table 6. Global Hepatitis A Vaccine Revenue by Region (2020-2025) & (US$ Million)
Table 7. Global Hepatitis A Vaccine Revenue Forecast by Region (2026-2031) & (US$ Million)
Table 8. Global Hepatitis A Vaccine Sales Volume by Type (2020-2025) & (K Unit)
Table 9. Global Hepatitis A Vaccine Sales Volume by Type (2026-2031) & (K Unit)
Table 10. Global Hepatitis A Vaccine Revenue by Type (2020-2025) & (US$ Million)
Table 11. Global Hepatitis A Vaccine Revenue Forecast by Type (2026-2031) & (US$ Million)
Table 12. Global Hepatitis A Vaccine Sales Volume by Application (2020-2025) & (K Unit)
Table 13. Global Hepatitis A Vaccine Sales Volume by Application (2026-2031) & (K Unit)
Table 14. Global Hepatitis A Vaccine Revenue by Application (2020-2025) & (US$ Million)
Table 15. Global Hepatitis A Vaccine Revenue by Application (2026-2031) & (US$ Million)
Table 16. Global Hepatitis A Vaccine Sales by Manufacturer (2020-2025) & (K Unit)
Table 17. Global Hepatitis A Vaccine Sales Share by Manufacturer (2020-2025)
Table 18. Hepatitis A Vaccine Revenue by Manufacturer (2020-2025) & (US$ Million)
Table 19. Hepatitis A Vaccine Revenue Share by Manufacturer (2020-2025)
Table 20. Key Manufacturers Hepatitis A Vaccine Price (2020-2025) & (USD/Unit)
Table 21. Ranking of Global Top Hepatitis A Vaccine Manufacturers by Revenue (US$ Million) in 2024
Table 22. Global Hepatitis A Vaccine Manufacturers Market Concentration Ratio (CR5 and HHI) & (2020-2025)
Table 23. Global Hepatitis A Vaccine by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Hepatitis A Vaccine as of 2024)
Table 24. Hepatitis A Vaccine Manufacturers Manufacturing Base Distribution and Headquarters
Table 25. Date of International Manufacturers Enter into Hepatitis A Vaccine Market
Table 26. Manufacturers Hepatitis A Vaccine Product Type and Application
Table 27. Manufacturers Mergers & Acquisitions, Expansion Plans
Table 28. GSK Company Information
Table 29. GSK Description and Business Overview
Table 30. GSK Hepatitis A Vaccine Product
Table 31. GSK Hepatitis A Vaccine Sales (K Unit), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)
Table 32. GSK Sales Proportion of Hepatitis A Vaccine by Product in 2024
Table 33. GSK Sales Proportion of Hepatitis A Vaccine by Application in 2024
Table 34. GSK Sales Proportion of Hepatitis A Vaccine by Geographic Area in 2024
Table 35. GSK Recent Developments
Table 36. Merck Company Information
Table 37. Merck Description and Business Overview
Table 38. Merck Hepatitis A Vaccine Product
Table 39. Merck Hepatitis A Vaccine Sales (K Unit), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)
Table 40. Merck Sales Proportion of Hepatitis A Vaccine by Product in 2024
Table 41. Merck Sales Proportion of Hepatitis A Vaccine by Application in 2024
Table 42. Merck Sales Proportion of Hepatitis A Vaccine by Geographic Area in 2024
Table 43. Merck Recent Developments
Table 44. Sanofi Company Information
Table 45. Sanofi Description and Business Overview
Table 46. Sanofi Hepatitis A Vaccine Product
Table 47. Sanofi Hepatitis A Vaccine Sales (K Unit), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)
Table 48. Sanofi Sales Proportion of Hepatitis A Vaccine by Product in 2024
Table 49. Sanofi Sales Proportion of Hepatitis A Vaccine by Application in 2024
Table 50. Sanofi Sales Proportion of Hepatitis A Vaccine by Geographic Area in 2024
Table 51. Sanofi Recent Developments
Table 52. Sinovac Company Information
Table 53. Sinovac Description and Business Overview
Table 54. Sinovac Hepatitis A Vaccine Product
Table 55. Sinovac Hepatitis A Vaccine Sales (K Unit), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)
Table 56. Sinovac Sales Proportion of Hepatitis A Vaccine by Product in 2024
Table 57. Sinovac Sales Proportion of Hepatitis A Vaccine by Application in 2024
Table 58. Sinovac Sales Proportion of Hepatitis A Vaccine by Geographic Area in 2024
Table 59. Sinovac Recent Developments
Table 60. Zhejiang Pukang Company Information
Table 61. Zhejiang Pukang Description and Business Overview
Table 62. Zhejiang Pukang Hepatitis A Vaccine Product
Table 63. Zhejiang Pukang Hepatitis A Vaccine Sales (K Unit), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)
Table 64. Zhejiang Pukang Sales Proportion of Hepatitis A Vaccine by Product in 2024
Table 65. Zhejiang Pukang Sales Proportion of Hepatitis A Vaccine by Application in 2024
Table 66. Zhejiang Pukang Sales Proportion of Hepatitis A Vaccine by Geographic Area in 2024
Table 67. Zhejiang Pukang Recent Developments
Table 68. Changchun Institute of Biological Company Information
Table 69. Changchun Institute of Biological Description and Business Overview
Table 70. Changchun Institute of Biological Hepatitis A Vaccine Product
Table 71. Changchun Institute of Biological Hepatitis A Vaccine Sales (K Unit), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)
Table 72. Changchun Institute of Biological Sales Proportion of Hepatitis A Vaccine by Product in 2024
Table 73. Changchun Institute of Biological Sales Proportion of Hepatitis A Vaccine by Application in 2024
Table 74. Changchun Institute of Biological Sales Proportion of Hepatitis A Vaccine by Geographic Area in 2024
Table 75. Changchun Institute of Biological Recent Developments
Table 76. KM Biologics Company Information
Table 77. KM Biologics Description and Business Overview
Table 78. KM Biologics Hepatitis A Vaccine Product
Table 79. KM Biologics Hepatitis A Vaccine Sales (K Unit), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)
Table 80. KM Biologics Sales Proportion of Hepatitis A Vaccine by Product in 2024
Table 81. KM Biologics Sales Proportion of Hepatitis A Vaccine by Application in 2024
Table 82. KM Biologics Sales Proportion of Hepatitis A Vaccine by Geographic Area in 2024
Table 83. KM Biologics Recent Developments
Table 84. IMBCAMS Company Information
Table 85. IMBCAMS Description and Business Overview
Table 86. IMBCAMS Hepatitis A Vaccine Product
Table 87. IMBCAMS Hepatitis A Vaccine Sales (K Unit), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)
Table 88. IMBCAMS Sales Proportion of Hepatitis A Vaccine by Product in 2024
Table 89. IMBCAMS Sales Proportion of Hepatitis A Vaccine by Application in 2024
Table 90. IMBCAMS Sales Proportion of Hepatitis A Vaccine by Geographic Area in 2024
Table 91. IMBCAMS Recent Developments
Table 92. Convac Company Information
Table 93. Convac Description and Business Overview
Table 94. Convac Hepatitis A Vaccine Product
Table 95. Convac Hepatitis A Vaccine Sales (K Unit), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)
Table 96. Convac Sales Proportion of Hepatitis A Vaccine by Product in 2024
Table 97. Convac Sales Proportion of Hepatitis A Vaccine by Application in 2024
Table 98. Convac Sales Proportion of Hepatitis A Vaccine by Geographic Area in 2024
Table 99. Convac Recent Developments
Table 100. North America Hepatitis A Vaccine Sales by Country (2020-2025) & (K Unit)
Table 101. North America Hepatitis A Vaccine Sales by Country (2026-2031) & (K Unit)
Table 102. North America Hepatitis A Vaccine Revenue by Country (2020-2025) & (US$ Million)
Table 103. North America Hepatitis A Vaccine Revenue by Country (2026-2031) & (US$ Million)
Table 104. North America Hepatitis A Vaccine Sales by Type (2020-2025) & (K Unit)
Table 105. North America Hepatitis A Vaccine Sales by Application (2020-2025) & (K Unit)
Table 106. Asia-Pacific Hepatitis A Vaccine Sales by Region (2020-2025) & (K Unit)
Table 107. Asia-Pacific Hepatitis A Vaccine Sales by Region (2026-2031) & (K Unit)
Table 108. Asia-Pacific Hepatitis A Vaccine Revenue by Region (2020-2025) & (US$ Million)
Table 109. Asia-Pacific Hepatitis A Vaccine Revenue by Region (2026-2031) & (US$ Million)
Table 110. Asia-Pacific Hepatitis A Vaccine Sales by Type (2020-2025) & (K Unit)
Table 111. Asia-Pacific Hepatitis A Vaccine Sales by Application (2020-2025) & (K Unit)
Table 112. Europe Hepatitis A Vaccine Sales by Country (2020-2025) & (K Unit)
Table 113. Europe Hepatitis A Vaccine Sales by Country (2026-2031) & (K Unit)
Table 114. Europe Hepatitis A Vaccine Revenue by Country (2020-2025) & (US$ Million)
Table 115. Europe Hepatitis A Vaccine Revenue by Country (2026-2031) & (US$ Million)
Table 116. Europe Hepatitis A Vaccine Sales by Type (2020-2025) & (K Unit)
Table 117. Europe Hepatitis A Vaccine Sales by Application (2020-2025) & (K Unit)
Table 118. Latin America Hepatitis A Vaccine Sales by Country (2020-2025) & (K Unit)
Table 119. Latin America Hepatitis A Vaccine Sales by Country (2026-2031) & (K Unit)
Table 120. Latin America Hepatitis A Vaccine Revenue by Country (2020-2025) & (US$ Million)
Table 121. Latin America Hepatitis A Vaccine Revenue by Country (2026-2031) & (US$ Million)
Table 122. Latin America Hepatitis A Vaccine Sales by Type (2020-2025) & (K Unit)
Table 123. Latin America Hepatitis A Vaccine Sales by Application (2020-2025) & (K Unit)
Table 124. Middle East and Africa Hepatitis A Vaccine Sales by Country (2020-2025) & (K Unit)
Table 125. Middle East and Africa Hepatitis A Vaccine Sales by Country (2026-2031) & (K Unit)
Table 126. Middle East and Africa Hepatitis A Vaccine Revenue by Country (2020-2025) & (US$ Million)
Table 127. Middle East and Africa Hepatitis A Vaccine Revenue by Country (2026-2031) & (US$ Million)
Table 128. Middle East and Africa Hepatitis A Vaccine Sales by Type (2020-2025) & (K Unit)
Table 129. Middle East and Africa Hepatitis A Vaccine Sales by Application (2020-2025) & (K Unit)
Table 130. Hepatitis A Vaccine Key Raw Materials, Industry Status and Trend
Table 131. Hepatitis A Vaccine Key Raw Materials and Upstream Suppliers
Table 132. Hepatitis A Vaccine Clients Status and Trend
Table 133. Hepatitis A Vaccine Typical Clients
Table 134. Hepatitis A Vaccine Distributors
Table 135. Hepatitis A Vaccine Market Trends
Table 136. Hepatitis A Vaccine Market Drivers
Table 137. Hepatitis A Vaccine Market Challenges
Table 138. Hepatitis A Vaccine Market Restraints
Table 139. Research Programs/Design for This Report
Table 140. Key Data Information from Secondary Sources
Table 141. Key Data Information from Primary Sources
Table 142. QYR Business Unit and Senior & Team Lead Analysts
List of Figures
Figure 1. Hepatitis A Vaccine Product Picture
Figure 2. Global Hepatitis A Vaccine Market Size by Type (US$ Million): 2020 VS 2024 VS 2031
Figure 3. Global Hepatitis A Vaccine Sales Market Share by Type in 2024 & 2031
Figure 4. Inactivated Vaccine Product Picture
Figure 5. Live Attenuated Vaccine Product Picture
Figure 6. Global Hepatitis A Vaccine Market Size by Application (US$ Million): 2020 VS 2024 VS 2031
Figure 7. Global Hepatitis A Vaccine Sales Market Share by Application in 2024 & 2031
Figure 8. Government Institution
Figure 9. Private Sector
Figure 10. Other
Figure 11. Hepatitis A Vaccine Report Years Considered
Figure 12. Global Hepatitis A Vaccine Revenue, (US$ Million), 2020 VS 2024 VS 2031
Figure 13. Global Hepatitis A Vaccine Market Size 2020-2031 (US$ Million)
Figure 14. Global Hepatitis A Vaccine Sales 2020-2031 (K Unit)
Figure 15. Global Hepatitis A Vaccine Sales Market Share Forecast by Region (2020-2031)
Figure 16. Global Hepatitis A Vaccine Revenue Market Share by Region (2020-2031)
Figure 17. Global Hepatitis A Vaccine Sales Market Share Forecast by Type (2020-2031)
Figure 18. Global Hepatitis A Vaccine Revenue Market Share Forecast by Type (2020-2031)
Figure 19. Hepatitis A Vaccine Average Selling Price (ASP) by Type (2020-2025) & (USD/Unit)
Figure 20. Global Hepatitis A Vaccine Sales Market Share Forecast by Application (2020-2031)
Figure 21. Global Hepatitis A Vaccine Revenue Market Share Forecast by Application (2020-2031)
Figure 22. Hepatitis A Vaccine Average Selling Price (ASP) by Application (2020-2025) & (USD/Unit)
Figure 23. Inactivated Vaccine of Hepatitis A Vaccine Revenue Market Share by Application, 2024 VS 2031
Figure 24. Live Attenuated Vaccine of Hepatitis A Vaccine Revenue Market Share by Application, 2024 VS 2031
Figure 25. Global Hepatitis A Vaccine Sales Share by Manufacturer in 2024
Figure 26. Hepatitis A Vaccine Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2020 VS 2024
Figure 27. Inactivated Vaccine Market Sales Proportion by Manufacturer in 2024
Figure 28. Live Attenuated Vaccine Market Sales Proportion by Manufacturer in 2024
Figure 29. North America Hepatitis A Vaccine Revenue 2020-2031 (US$ Million)
Figure 30. North America Hepatitis A Vaccine Sales Market Share by Type (2020-2025)
Figure 31. North America Hepatitis A Vaccine Sales Market Share by Application (2020-2025)
Figure 32. Asia-Pacific Hepatitis A Vaccine Revenue 2020-2031 (US$ Million)
Figure 33. Asia-Pacific Hepatitis A Vaccine Sales Market Share by Region (2020-2031)
Figure 34. Asia-Pacific Hepatitis A Vaccine Revenue Market Share by Region (2020-2031)
Figure 35. Asia-Pacific Hepatitis A Vaccine Sales Market Share by Type (2020-2025)
Figure 36. Asia-Pacific Hepatitis A Vaccine Sales Market Share by Application (2020-2025)
Figure 37. Europe Hepatitis A Vaccine Revenue Growth Rate 2020-2031 (US$ Million)
Figure 38. Europe Hepatitis A Vaccine Sales Market Share by Country (2020-2031)
Figure 39. Europe Hepatitis A Vaccine Revenue Market Share by Country (2020-2031)
Figure 40. Europe Hepatitis A Vaccine Sales Market Share by Type (2020-2025)
Figure 41. Europe Hepatitis A Vaccine Sales Market Share by Application (2020-2025)
Figure 42. Latin America Hepatitis A Vaccine Revenue Growth Rate 2020-2031 (US$ Million)
Figure 43. Latin America Hepatitis A Vaccine Sales Market Share by Country (2020-2031)
Figure 44. Latin America Hepatitis A Vaccine Revenue Market Share by Country (2020-2025)
Figure 45. Latin America Hepatitis A Vaccine Sales Market Share by Type (2020-2025)
Figure 46. Latin America Hepatitis A Vaccine Sales Market Share by Application (2020-2025)
Figure 47. Middle East and Africa Hepatitis A Vaccine Revenue Growth Rate 2020-2031 (US$ Million)
Figure 48. Middle East and Africa Hepatitis A Vaccine Sales Market Share by Country (2020-2031)
Figure 49. Middle East and Africa Hepatitis A Vaccine Revenue Market Share by Country (2020-2031)
Figure 50. Middle East and Africa Hepatitis A Vaccine Sales Market Share by Type (2020-2025)
Figure 51. Middle East and Africa Hepatitis A Vaccine Sales Market Share by Application (2020-2025)
Figure 52. Hepatitis A Vaccine Supply Chain (Upstream and Downstream Market)
Figure 53. Global Production Market Share of Hepatitis A Vaccine Raw Materials by Region in 2024
Figure 54. Hepatitis A Vaccine Distribution Channels
Figure 55. Global Hepatitis A Vaccine Percentage 2020-2031: Indirect Sales VS Direct Sales
Figure 56. Global Hepatitis A Vaccine Percentage 2020-2031: Online Sales VS Offline Sales
Figure 57. Bottom-up and Top-down Approaches for This Report
Figure 58. Data Triangulation
Figure 59. Key Executives Interviewed
Our team would be happy to assist you with your queries.
About us
Accurate data, The latest market trends, And deeper research directions.
Our sole purpose is to provide a basis for leaders in all walks of life to make more appropriate decisions, to help companies solve existing problems and achieve business goals
Latest reports
Global Medical Waste Fluid Solidifier Market Research Report 2025
Jun 12, 25
Global Metalized Bubble Material Market Research Report 2025
Jun 12, 25
Global 70% Isopropyl Rubbing Alcohol Market Research Report 2025
Jun 12, 25
Useful links
Our Contacts
Room 2306, T6 Fuxing World Financial Center, Kaifu District, Changsha, Hunan, China
(+86) 159 1069 5232